Tapping Chinese investors, Apexigen closes $73M for 8 trials in I/O
Apexigen, a small company in California, just closed a couple rounds of cash totaling $73 million — mostly from Chinese investors — to push forward …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
